Three-year follow-up results of polypectomy with endometrial ablation in the management of endometrial polyps associated with tamoxifen in Chinese women

Wanli Gao, Luping Zhang, Wenjun Li, Wen‐Jun Li, Jinghua Li, Weijuan Wang, Wang Wei-juan, Weihong Zhao, Limin Feng
European journal of obstetrics, gynecology, and reproductive biology · 2012 · vol. 161(1) , pp. 62–65 · doi:10.1016/j.ejogrb.2011.10.014 · PMID:22310944 · W1969347363
Other OA: closed CC0 ⤵ 3 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-29 ⓘ

Hysteroscopic polypectomy with endometrial ablation for tamoxifen-associated endometrial polyps in postmenopausal women showed a low recurrence rate, high symptomatic relief, and avoidance of hysterectomy over a 3-year follow-up.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: The aim of this study was to investigate the role of hysteroscopic polypectomy with endometrial ablation in the management of tamoxifen-associated endometrial polyps in postmenopausal women with a more than 3-year follow-up period. STUDY DESIGN: The medical records of 76 postmenopausal patients on tamoxifen who were performed hysteroscopic polypectomy with endometrial ablation were evaluated more than 3 years after the procedure with recurrence of polyps, recurrent abnormal uterine bleeding and surgical re-intervention. RESULTS: Average follow-up period was 74.91 ± 20.84 months. No patient underwent hysterectomy, 7 of 76 patients had a surgical re-intervention representing a total of 90.8% avoidance of additional surgery during the follow-up period, and 4 patients had a recurrent endometrial polyp representing the recurrence rate was 5.3%. 3 of 41 patients with postmenopausal bleeding had a recurrent abnormal uterine bleeding representing symptomatic relief rate is 92.7%. The treatment failed in 7 patients who requested surgical re-intervention: 4 patients requested a repeat polypectomy and ablation, 1 patient requested a repeat ablation and 2 patients requested a repeat hysteroscopy with uterine adhesion. No malignant endometrial pathological result was found. CONCLUSIONS: For postmenopausal patients suffering from endometrial polyps associated with tamoxifen, hysteroscopic polypectomy with endometrial ablation continues to be proven as a safe and effective minimally invasive treatment method. The high rate of surgical re-intervention avoidance, great symptomatic relief and low recurrence rate are very encouraging for this technology.

My notes (saved in your browser only)

MeSH descriptors

Endometrial Ablation Techniques Polyps Tamoxifen Uterine Neoplasms Adult Aged Asian People Breast Neoplasms Female Follow-Up Studies Humans Hysteroscopy Middle Aged Polyps Postmenopause Recurrence Reoperation Retrospective Studies Tamoxifen Treatment Outcome

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (3)

References (27)

Cited by (3)

Source provenance

openalex
last seen: 2026-05-11T05:51:57.177246+00:00
pubmed
last seen: 2026-10-08T21:09:51.187616+00:00
License: CC0 · commercial use OK